LOSS OF HETEROZYGOSITY OF TUMOR-SUPPRESSOR GENES IN TESTIS CANCER

被引:0
|
作者
PENG, HQ
BAILEY, D
BRONSON, D
GOSS, PE
HOGG, D
机构
[1] TORONTO HOSP, DIV ONCOL RES, TORONTO, ON M5G 2C4, CANADA
[2] TORONTO HOSP, DEPT PATHOL, TORONTO, ON M5G 2C4, CANADA
[3] UNIV MINNESOTA, SCH MED, DEPT UROL, MINNEAPOLIS, MN 55455 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Little is known of the molecular changes that occur in germ cell tumors (GCT) of the testis. We studied three GCT cell lines and 44 tumors for loss of heterozygosity (LOH) of the tumor suppressor genes APC, MCC, DCC, RE, TP53, and WT-1. We observed that LOH occurred in 55% (21 of 38) of informative cases at DCC, in 28% (10 of 36) of informative cases at APC,in 23% (6 of 26) at MCC, in 30% (13 of 43) at RB, and in 27% (6 of 22) at WT-1. The LOH level in these tumors using anonymous primers mapping to the short and long arms of chromosome 19, which is cytogenetically normal in GCT, revealed LOH of 11 and 5%, respectively. We also observed a LOH of 22% in the TP53 gene, despite the fact that mutations in TP53 do not occur in testis cancer. Since a high frequency of LOH at DCC (18q21.3) occurs equally at all histological subsets in GCT, we conclude that the loss of the function of this gene is an early event in testicular GCTs. However, the observed LOH levels at APC/MCC (5q21), RE (13q14), and WT-1 (11p13) could represent a functional loss of the corresponding tumor suppressor gene in some GCTs or reflect the loss of sequences in the same general chromosome region but involving a different tumor suppressor locus. Therefore, detailed mapping of these chromosomes is required to define the precise locations of maximal LOH in testis cancer.
引用
收藏
页码:2871 / 2875
页数:5
相关论文
共 50 条
  • [1] SEARCHING FOR TUMOR-SUPPRESSOR GENES - CHROMOSOMAL DELETIONS AND LOSS OF HETEROZYGOSITY IN HUMAN TUMORS
    BERGER, R
    BULLETIN DU CANCER, 1993, 80 (08) : 713 - 716
  • [2] TUMOR-SUPPRESSOR GENES
    HINDS, PW
    WEINBERG, RA
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 1994, 4 (01) : 135 - 141
  • [3] THE TUMOR-SUPPRESSOR GENES
    LEVINE, AJ
    ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 : 623 - 651
  • [4] TUMOR-SUPPRESSOR GENES
    CORDONCARDO, C
    CANCER, 1995, 75 (10) : 2641 - 2641
  • [5] TUMOR-SUPPRESSOR GENES
    WEINBERG, R
    NEURON, 1993, 11 (02) : 191 - 196
  • [6] TUMOR-SUPPRESSOR GENES IN OVARIAN-CANCER
    FOULKES, W
    BRITISH MEDICAL JOURNAL, 1993, 307 (6910): : 1009 - 1009
  • [7] LOSS OF HETEROZYGOSITY OF TUMOR-SUPPRESSOR GENE LOCI IN HUMAN COLORECTAL-CARCINOMA
    IACOPETTA, B
    DIGRANDI, S
    DIX, B
    HAIG, C
    SOONG, R
    HOUSE, A
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (05) : 664 - 670
  • [8] INFREQUENT LOSS OF HETEROZYGOSITY (LOH) AT TUMOR-SUPPRESSOR GENE LOCI IN GALLBLADDER NEOPLASIA
    SATO, J
    KAWAMOTO, T
    CHERIAN, S
    SATO, M
    FUKUTOMI, H
    FUKAO, T
    BOLAND, CR
    GASTROENTEROLOGY, 1994, 106 (04) : A437 - A437
  • [9] Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma
    Yip, Linwah
    Seethala, Raja R.
    Nikiforova, Marina N.
    Nikiforov, Yuri E.
    Ogilvie, Jennifer B.
    Carty, Sally E.
    Yim, John H.
    SURGERY, 2008, 144 (06) : 949 - 954
  • [10] FREQUENT LOSS OF EXPRESSION AND LOSS OF HETEROZYGOSITY OF THE PUTATIVE TUMOR-SUPPRESSOR GENE DCC IN PROSTATIC CARCINOMAS
    GAO, X
    HONN, KV
    GRIGNON, D
    SAKR, W
    CHEN, YQ
    CANCER RESEARCH, 1993, 53 (12) : 2723 - 2727